Raymond James & Associates’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,127
| Closed | -$55.7K | – | 3921 |
|
|
2023
Q1 | $55.7K | Sell |
6,127
-652
| -10% | -$5.93K | ﹤0.01% | 3677 |
|
|
2022
Q4 | $79.5K | Sell |
6,779
-2,961
| -30% | -$34.7K | ﹤0.01% | 3623 |
|
|
2022
Q3 | $206K | Sell |
9,740
-4,643
| -32% | -$98.2K | ﹤0.01% | 3405 |
|
|
2022
Q2 | $349K | Sell |
14,383
-8,168
| -36% | -$198K | ﹤0.01% | 3122 |
|
|
2022
Q1 | $1.12M | Buy |
22,551
+2,088
| +10% | +$104K | ﹤0.01% | 2504 |
|
|
2021
Q4 | $1.44M | Sell |
20,463
-6,302
| -24% | -$442K | ﹤0.01% | 2391 |
|
|
2021
Q3 | $2.5M | Sell |
26,765
-137
| -0.5% | -$12.8K | ﹤0.01% | 1941 |
|
|
2021
Q2 | $2.7M | Buy |
26,902
+880
| +3% | +$88.5K | ﹤0.01% | 1888 |
|
|
2021
Q1 | $2.43M | Buy |
26,022
+1,384
| +6% | +$129K | ﹤0.01% | 1880 |
|
|
2020
Q4 | $2.03M | Buy |
24,638
+74
| +0.3% | +$6.11K | ﹤0.01% | 1879 |
|
|
2020
Q3 | $2.11M | Buy |
24,564
+19,988
| +437% | +$1.72M | ﹤0.01% | 1735 |
|
|
2020
Q2 | $426K | Buy |
4,576
+2,192
| +92% | +$204K | ﹤0.01% | 2686 |
|
|
2020
Q1 | $68K | Sell |
2,384
-2,343
| -50% | -$66.8K | ﹤0.01% | 3249 |
|
|
2019
Q4 | $196K | Buy |
+4,727
| New | +$196K | ﹤0.01% | 3323 |
|